COMMUNIQUÉS West-GlobeNewswire

IBA SA : Notification de transparence
13/04/2018
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 13 avril 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
Vistin Pharma ASA : Annual Report for 2017
13/04/2018
Oslo, Norway, 13 April 2018 The Board of Directors of Vistin Pharma ASA has on 13 April 2018 approved the Directors' report and consolidated financial statements for Vistin Pharma for 2017. The annual report for 2017 is [...]
BioPorto A/S - Annual General Meeting
13/04/2018
April 13, 2018 Announcement no. 8 BioPorto A/S held its Annual General Meeting today where the shareholders approved the report on the Company’s activities and adopted the 2017 Annual Report. In addition, the general [...]
Sienna Announces April Dividend
13/04/2018
MARKHAM, Ontario, April 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) [...]
Summit Therapeutics Files US Annual Report on Form 20F
13/04/2018
Summit Therapeutics plc ("Summit", or the "Company") Summit Therapeutics Files US Annual Report on Form 20-F Oxford, UK, and Cambridge, MA, US, 13 April 2018 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT) provides [...]
Progressive Care Reports 20% Increase in Year over Year Prescriptions Filled During March 2018
13/04/2018
MIAMI, April 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced increased prescriptions filled and revenue for March 2018. PharmCo, LLC filled over [...]
Calithera Biosciences to Present New Preclinical Data for CB-839 at AACR Annual Meeting 2018
13/04/2018
Synergy of CB-839 with CDK4/6 and PARP inhibitors SOUTH SAN FRANCISCO, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the [...]
Ceapro Inc. to Present at the 12th International Symposium on Supercritical Fluids
13/04/2018
EDMONTON, Alberta, April 13, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]
Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification
13/04/2018
DANVERS, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD ) announced that on Thursday, May 3, 2018, the Company will release financial results for the fourth quarter of fiscal 2018. The Company [...]
CRISPR Therapeutics to Present Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
13/04/2018
ZUG, Switzerland and CAMBRIDGE, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Olerup QTYPE® Receives CE Mark Certification
13/04/2018
Fastest real time typing with Olerup QTYPE is now broadly available BRISBANE, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, [...]
BioCorRx to Participate in the First Annual Orange County Recovery Collaborative Resource Fair
13/04/2018
ANAHEIM, CA, April 13, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addition, today announced that the [...]
Liver Biopsy Data from POISE Phase 3 Substudy Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients
13/04/2018
11 of 13 patients improved or maintained histological fibrosis stage after three years of treatment with obeticholic acid (OCA) NEW YORK, April 13, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT [...]
EyeGate Announces $11.25 Million Public Offering
13/04/2018
WALTHAM, Mass., April 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform [...]
Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia
13/04/2018
Six abstracts support lefamulin as a potential first-in-class pleuromutilin antibiotic targeting CABP pathogens, including drug resistant phenotypes DUBLIN, Ireland, April 13, 2018 (GLOBE NEWSWIRE) -- Nabriva [...]
Rhizen Pharmaceuticals S.A. receives FDA Fast Track Designation for Tenalisib (RP6530), a highly selective dual PI3K delta/gamma inhibitor for the treatment of patients with relapsed and/or refractory Cutaneous T-cell Lymphoma (CTCL)
13/04/2018
La Chaux-de-Fonds, Switzerland, April 13, 2018 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Tenalisib (RP6530 [...]
Shire plc: Form 8 Opening Position Disclosure - Takeda Pharmaceutical Company Limited
13/04/2018
FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Shire plc (b) Owner or controller of interests [...]
Shire plc: Form 8 Opening Position Disclosure - Shire plc
13/04/2018
FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Shire plc (b) Owner or controller of interests [...]
MediciNova Announces Presentation of Significant Positive Results from Interim Analysis of the Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD at the International Liver Congress 2018 in Paris, France
13/04/2018
LA JOLLA, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Pages